Revatio 20 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F3P4B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,550
Award facts
- Contract value 100% obligated
- $29,550.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of Revatio 20 mg tablets (90-count units) at a ceiling value of $29,550.29. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with ultimate completion scheduled for January 12, 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), which serves as the parent organization in this transaction.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive pharmaceutical supply agreement valued at up to $999,999,999.00 through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling the company to supply a broad range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. The contract encompasses deliveries to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with AmerisourceBergen demonstrating substantial capability to meet federal medical procurement requirements through competitive procurement processes across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F3P4B?
SPE2DR26F3P4B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F3P4B worth?
The government has obligated $29,550 on SPE2DR26F3P4B.
Is contract SPE2DR26F3P4B an order under another contract?
Yes. SPE2DR26F3P4B is a delivery order under SPE2DR25D3008, an indefinite delivery contract.
Was contract SPE2DR26F3P4B competed?
The extent of competition for SPE2DR26F3P4B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award